全文获取类型
收费全文 | 6131篇 |
免费 | 577篇 |
国内免费 | 17篇 |
专业分类
耳鼻咽喉 | 97篇 |
儿科学 | 314篇 |
妇产科学 | 185篇 |
基础医学 | 935篇 |
口腔科学 | 95篇 |
临床医学 | 942篇 |
内科学 | 1253篇 |
皮肤病学 | 78篇 |
神经病学 | 350篇 |
特种医学 | 426篇 |
外国民族医学 | 2篇 |
外科学 | 586篇 |
综合类 | 99篇 |
一般理论 | 12篇 |
预防医学 | 599篇 |
眼科学 | 53篇 |
药学 | 372篇 |
中国医学 | 8篇 |
肿瘤学 | 319篇 |
出版年
2021年 | 91篇 |
2020年 | 50篇 |
2019年 | 79篇 |
2018年 | 115篇 |
2017年 | 72篇 |
2016年 | 101篇 |
2015年 | 107篇 |
2014年 | 116篇 |
2013年 | 151篇 |
2012年 | 225篇 |
2011年 | 241篇 |
2010年 | 156篇 |
2009年 | 165篇 |
2008年 | 276篇 |
2007年 | 238篇 |
2006年 | 223篇 |
2005年 | 203篇 |
2004年 | 228篇 |
2003年 | 212篇 |
2002年 | 196篇 |
2001年 | 194篇 |
2000年 | 219篇 |
1999年 | 159篇 |
1998年 | 131篇 |
1997年 | 106篇 |
1996年 | 115篇 |
1995年 | 105篇 |
1994年 | 98篇 |
1993年 | 100篇 |
1992年 | 155篇 |
1991年 | 138篇 |
1990年 | 140篇 |
1989年 | 166篇 |
1988年 | 143篇 |
1987年 | 139篇 |
1986年 | 137篇 |
1985年 | 136篇 |
1984年 | 82篇 |
1983年 | 72篇 |
1982年 | 64篇 |
1981年 | 60篇 |
1980年 | 45篇 |
1979年 | 69篇 |
1978年 | 62篇 |
1977年 | 68篇 |
1976年 | 54篇 |
1975年 | 53篇 |
1974年 | 66篇 |
1973年 | 44篇 |
1970年 | 41篇 |
排序方式: 共有6725条查询结果,搜索用时 31 毫秒
1.
Intracranial venous thrombosis has been described in newborns, but there have been no reports of intractable neonatal seizures due to this condition. We report cortical venous sinus thrombosis in two term neonates who presented with seizures in the first 24 hours of life. The diagnosis was made by cranial computed tomography and was confirmed by cerebral angiography. Both patients improved clinically after the intracranial venous thrombosis resolved. These patients demonstrate that intracranial venous thrombosis should be considered in the differential diagnosis of neonatal seizures. 相似文献
2.
ME BURGE AM JOSHUA CM McNEIL R HUI MJ BOYER R ABRAHAM 《Asia-Pacific Journal of Clinical Oncology》2005,1(1):47-52
Background: Pemetrexed and cisplatin have recently been shown to significantly improve survival compared with cisplatin alone. However, there are only limited data reflecting teaching hospital experience outside a clinical trial. Pemetrexed has only been available in Australia on a restricted basis since 2002. We reviewed our experience of patients treated on the Australian ‘Special Access Scheme’ at three major thoracic oncology units. Methods: Charts were reviewed for all patients enrolled on the scheme. Data was extracted on age, World Health Organization (WHO) performance status, histology, prior therapy, time from diagnosis to starting pemetrexed, chemotherapy (pemetrexed alone or with a platinum), cycle number, response rate, actuarial progression‐free and overall survival. Doses were cisplatin 75 mg/m2 or carboplatin AUC = 5 and pemetrexed 500 mg/m2 every 21 days. Results: 52 patients (32 male and 20 female) were reviewed. Median age was 58 years and 88% were WHO 0–1. Histology included 54% epithelial, 17% biphasic (epithelial and sarcomatoid) and 21% undefined. The median time from diagnosis to administration of pemetrexed was 145 days. Sixty‐five percent had minimal surgical intervention with video assisted thoracoscopy, pleurodesis and biopsy, while 19% had received prior palliative radiation. Seventy‐one percent were chemotherapy naïve, the remaining 29% having received previous platinum and/or gemcitabine regimens. Twenty‐three percent had pemetrexed alone, 35% in combination with carboplatin and 42% with cisplatin. The median number of cycles was 4 (range 1–13). The response rate was 33%. No toxicity was observed in 20% grade 3–4 toxicity in 10% (majority nausea/vomiting). The median progression‐free and overall survival times from starting pemetrexed were 184 days and 298 days, respectively. Conclusions: Pemetrexed‐based regimens are safe and effective in a community setting in malignant mesothelioma. 相似文献
3.
Allergic autoimmune reaction after exposure to heavy metals such as mercury may play a causal role in autism, a developmental disorder of the central nervous system. As metallothionein (MT) is the primary metal-detoxifying protein in the body, we conducted a study of the MT protein and antibodies to metallothionein (anti-MT) in normal and autistic children whose exposure to mercury was only from thimerosal-containing vaccines. Laboratory analysis by immunoassays revealed that the serum level of MT did not significantly differ between normal and autistic children. Furthermore, autistic children harboured normal levels of anti-MT, including antibodies to isoform MT-I (anti-MT-I) and MT-II (anti-MT-II), without any significant difference between normal and autistic children. Our findings indicate that because autistic children have a normal profile of MT and anti-MT, the mercury-induced autoimmunity to MT may not be implicated in the pathogenesis of autism. 相似文献
4.
5.
Quantification of Basal and Stimulated ROS Levels as Predictors of Islet Potency and Function 总被引:2,自引:0,他引:2
B. Armann M. S. Hanson E. Hatch A. Steffen L. A. Fernandez 《American journal of transplantation》2007,7(1):38-47
We have developed a luminol-based assay using intact islets, which allows for quantification of reactive oxygen species (ROS). In addition, an index capable of characterizing metabolic and mitochondrial integrity prior to transplantation was created based on the capacity of islets to respond to high glucose and rotenone (mitochondrial respiratory chain complex I inhibitor) by production of ROS. To validate this assay, lipid peroxidation and antioxidative defense capacity were evaluated by detection of malondialdehyde (MDA) levels and glutathione peroxidase activity (GPx), respectively. Also, flow cytometric analyses of ROS (dihydroethidine), apoptosis (Annexin V, active caspases), necrosis (Topro3), and mitochondrial membrane potential (JC-1) were done in parallel to correlate with changes in luminol-measured ROS. ATP/ADP ratios were quantified by HPLC and the predictive value of ROS measurement on islet functional potency was correlated with capacity to reverse diabetes in a streptozotocin-induced diabetic NOD.scid mouse model as well as in human transplant recipients. Our data demonstrate that levels of ROS in islets correlate with the percentage of apoptotic cells and their functional potency in vivo. The ROS indices following glucose and rotenone exposure are indicative of metabolic potency and mitochondrial integrity and can be used as surrogate markers to evaluate the quality of islets prior to transplantation. 相似文献
6.
7.
8.
Joyce J. Fitzpatrick Sheila Ryan DeWitt Baldwin Roger Bulger Jean Johnson-Pawlson Christopher McLaughlin Maureen Kelley Leopold Selketr Bernardine Lacey Charlene Hanson Robin Harvan Patricia Hinton Walker David Sluyter Mary Joan Ladden Neal Vanselow 《Journal of Midwifery & Women's Health》1998,43(1):61-65
In 1995, the National League for Nursing commissioned a Panel on Interdisciplinary/Transdisciplinary Education. The focus of the Panel's work was to examine educational issues that transcend the health professions and to make recommendations for future implementation of an interdisciplinary approach to addressing them. This article is being simultaneously published by several professional journals. The goal is to seek as much feedback as possible. 相似文献
9.
10.